Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Soheila Korourian

Concepts (303)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1200
2.700
Why?
Carcinoma, Ductal, Breast
9
2015
96
1.800
Why?
Mastectomy, Segmental
8
2015
94
1.490
Why?
Catheter Ablation
4
2014
136
1.260
Why?
Neoplasm Recurrence, Local
7
2014
576
1.200
Why?
Sentinel Lymph Node Biopsy
15
2017
120
1.190
Why?
Mastectomy
10
2018
139
1.140
Why?
Mammary Neoplasms, Experimental
7
2010
146
0.990
Why?
Biopsy, Needle
11
2017
202
0.970
Why?
Carcinoma in Situ
3
2008
70
0.950
Why?
Soybean Proteins
3
2019
171
0.910
Why?
Obesity
7
2019
1111
0.880
Why?
Lymph Nodes
12
2017
287
0.870
Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
58
0.870
Why?
Caseins
3
2019
86
0.830
Why?
Liver
8
2019
1239
0.710
Why?
DNA, Neoplasm
1
2018
177
0.700
Why?
Rats, Zucker
8
2019
59
0.580
Why?
Uterine Cervical Neoplasms
3
2007
278
0.580
Why?
Receptor, erbB-2
3
2018
85
0.570
Why?
Receptors, Estrogen
4
2018
149
0.540
Why?
Dietary Supplements
2
2015
431
0.540
Why?
Arginine
1
2015
185
0.530
Why?
Aged
32
2018
10017
0.520
Why?
Neoplasm Staging
15
2015
792
0.510
Why?
Female
51
2018
27910
0.490
Why?
Cervical Intraepithelial Neoplasia
3
2007
42
0.490
Why?
Middle Aged
34
2018
13149
0.490
Why?
Mammary Neoplasms, Animal
2
2015
40
0.490
Why?
Isoflavones
4
2017
83
0.460
Why?
Diet
2
2015
583
0.460
Why?
Ultrasonography, Mammary
4
2015
61
0.460
Why?
Dehydroepiandrosterone
1
2010
15
0.440
Why?
Carcinogens
3
2015
238
0.430
Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
46
0.430
Why?
Benz(a)Anthracenes
1
2010
36
0.430
Why?
Axilla
9
2017
96
0.410
Why?
Lymphatic Vessels
4
2014
47
0.410
Why?
Aged, 80 and over
15
2018
3496
0.380
Why?
Carcinoma, Ductal
1
2008
8
0.380
Why?
Plant Lectins
1
2008
11
0.380
Why?
Adult
25
2018
13861
0.360
Why?
Prognosis
11
2017
2057
0.360
Why?
Technetium Tc 99m Sulfur Colloid
6
2014
36
0.360
Why?
Rats
14
2019
3430
0.350
Why?
Electrosurgery
1
2007
10
0.350
Why?
Receptors, Progesterone
4
2018
89
0.340
Why?
Magnetic Resonance Imaging
4
2014
1592
0.340
Why?
Lymphedema
5
2017
43
0.340
Why?
Thinness
3
2017
55
0.330
Why?
Humans
47
2019
50276
0.330
Why?
Cytodiagnosis
4
2015
43
0.320
Why?
Lymphatic Metastasis
12
2015
251
0.320
Why?
Prospective Studies
12
2017
2349
0.310
Why?
Nipples
5
2013
32
0.310
Why?
Combined Modality Therapy
5
2014
701
0.300
Why?
Adenocarcinoma, Mucinous
1
2005
20
0.300
Why?
Follow-Up Studies
10
2015
2357
0.300
Why?
Endometritis
1
2004
8
0.290
Why?
Ethanol
5
2010
322
0.280
Why?
Proteoglycans
1
2004
96
0.280
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
38
0.270
Why?
Animals
18
2019
14247
0.270
Why?
Radiopharmaceuticals
6
2014
252
0.270
Why?
Laser Coagulation
1
2003
26
0.260
Why?
Proliferating Cell Nuclear Antigen
1
2003
86
0.260
Why?
Lymph Node Excision
6
2017
130
0.250
Why?
Carcinoma, Lobular
3
2015
33
0.250
Why?
Plasma Cells
1
2004
225
0.250
Why?
Membrane Glycoproteins
1
2004
291
0.250
Why?
Coloring Agents
4
2014
85
0.250
Why?
Neoplasm Invasiveness
5
2015
294
0.250
Why?
Mammaplasty
2
2013
41
0.240
Why?
Infant Food
1
2002
31
0.240
Why?
Biopsy, Fine-Needle
3
2015
118
0.230
Why?
Monitoring, Intraoperative
3
2014
67
0.220
Why?
Ovarian Neoplasms
1
2005
441
0.210
Why?
Paraffin Embedding
2
2018
57
0.210
Why?
Ultrasonography, Interventional
3
2011
148
0.210
Why?
Immunohistochemistry
9
2017
1129
0.200
Why?
Lung Neoplasms
3
2015
574
0.200
Why?
Retrospective Studies
13
2015
5676
0.200
Why?
Fatty Liver
2
2019
125
0.200
Why?
Biopsy
4
2007
686
0.200
Why?
Neoplasm Grading
3
2014
131
0.200
Why?
Body Weight
3
2017
577
0.190
Why?
Sensitivity and Specificity
8
2015
953
0.190
Why?
Adolescent
8
2015
6596
0.190
Why?
Tissue Fixation
1
2018
35
0.190
Why?
Specimen Handling
1
2018
59
0.180
Why?
Alanine Transaminase
3
2015
150
0.180
Why?
Soybeans
1
2017
51
0.170
Why?
Pulmonary Medicine
1
2015
16
0.160
Why?
Protein Hydrolysates
1
2015
5
0.150
Why?
Aspartate Aminotransferases
1
2015
60
0.150
Why?
Rats, Sprague-Dawley
7
2015
1729
0.150
Why?
Kaplan-Meier Estimate
2
2014
529
0.150
Why?
Treatment Outcome
5
2017
5421
0.150
Why?
Rosaniline Dyes
1
2014
8
0.150
Why?
Image-Guided Biopsy
1
2015
35
0.150
Why?
Sulfotransferases
1
2015
49
0.140
Why?
Dermatologic Surgical Procedures
2
2013
40
0.140
Why?
Vacuum
2
2011
13
0.140
Why?
Plant Extracts
1
2017
199
0.140
Why?
Melanoma
2
2011
303
0.140
Why?
Ultrasonography, Doppler
1
2014
58
0.130
Why?
Interleukin-6
1
2015
299
0.130
Why?
Young Adult
6
2015
4120
0.130
Why?
Carcinoma, Adenoid Cystic
1
2013
8
0.130
Why?
Intraoperative Care
2
2011
63
0.130
Why?
Patient Care Planning
1
2013
82
0.130
Why?
Tumor Necrosis Factor-alpha
1
2015
422
0.130
Why?
Disease-Free Survival
1
2014
520
0.120
Why?
Preoperative Care
1
2014
183
0.120
Why?
Lymphography
1
2011
10
0.120
Why?
Skin Neoplasms
2
2011
532
0.110
Why?
Image Processing, Computer-Assisted
2
2003
279
0.110
Why?
Frozen Sections
1
2011
16
0.110
Why?
Liver Neoplasms
2
2005
324
0.110
Why?
Cytoprotection
1
2010
49
0.110
Why?
Fatty Liver, Alcoholic
1
2010
8
0.110
Why?
DNA Methylation
1
2015
572
0.100
Why?
Feasibility Studies
1
2011
393
0.100
Why?
Clinical Competence
1
2013
430
0.100
Why?
Drug Evaluation, Preclinical
1
2010
157
0.100
Why?
Genistein
1
2010
64
0.100
Why?
Cell Line, Tumor
3
2010
1472
0.100
Why?
Hepatocytes
2
2008
207
0.100
Why?
Pilot Projects
1
2011
766
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1008
0.090
Why?
Radionuclide Imaging
4
2011
123
0.090
Why?
Hepatitis
1
2008
21
0.090
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
34
0.090
Why?
Protons
1
2007
68
0.090
Why?
Uterine Cervical Dysplasia
1
2007
18
0.090
Why?
Male
9
2019
27231
0.080
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
70
0.080
Why?
Ovariectomy
1
2007
128
0.080
Why?
Cytokines
2
2008
671
0.080
Why?
Organ Size
1
2007
259
0.080
Why?
Oligosaccharides
1
2005
41
0.080
Why?
Cystadenocarcinoma, Papillary
1
2005
16
0.080
Why?
Omentum
1
2005
17
0.080
Why?
Antibodies, Neoplasm
1
2005
38
0.070
Why?
Uterine Neoplasms
1
2005
65
0.070
Why?
Monosaccharide Transport Proteins
1
2004
16
0.070
Why?
Eosine Yellowish-(YS)
1
2004
6
0.070
Why?
Carcinoma, Small Cell
1
2004
26
0.070
Why?
Hematoxylin
1
2004
8
0.070
Why?
Syndecans
1
2004
46
0.070
Why?
Syndecan-1
1
2004
82
0.070
Why?
Endotoxins
1
2004
35
0.070
Why?
Aging
1
2010
740
0.070
Why?
Immunoenzyme Techniques
1
2004
173
0.070
Why?
Endometrium
1
2004
72
0.070
Why?
Liver Diseases, Alcoholic
1
2004
35
0.070
Why?
Cytological Techniques
1
2003
12
0.070
Why?
Lymphoma, Non-Hodgkin
1
2004
61
0.070
Why?
Carbohydrates
1
2004
64
0.070
Why?
Apoproteins
1
2003
11
0.070
Why?
Neoplasms
2
2004
1143
0.070
Why?
Neoplasms, Multiple Primary
1
2003
51
0.070
Why?
Malondialdehyde
1
2003
65
0.070
Why?
Dietary Fats
1
2004
142
0.060
Why?
Fatty Acids
1
2004
170
0.060
Why?
Overweight
1
2005
195
0.060
Why?
Aldehydes
1
2003
88
0.060
Why?
Cytochrome P-450 CYP2E1
3
2010
106
0.060
Why?
Cell Membrane
1
2004
271
0.060
Why?
Surgical Instruments
1
2002
44
0.060
Why?
Foreign-Body Migration
1
2002
34
0.060
Why?
Hematoma
3
2010
68
0.060
Why?
Breast Diseases
1
2002
34
0.060
Why?
Gene Expression
2
2019
701
0.060
Why?
Asia
1
2002
28
0.060
Why?
Risk Factors
1
2011
3860
0.060
Why?
Gene Expression Regulation
1
2008
1117
0.060
Why?
Chronic Disease
1
2004
611
0.060
Why?
Cost-Benefit Analysis
2
2015
273
0.060
Why?
Head and Neck Neoplasms
1
2004
302
0.050
Why?
Carcinoma, Squamous Cell
1
2004
387
0.050
Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.050
Why?
Neoplasm Metastasis
2
2015
258
0.050
Why?
Methyltransferases
1
2019
40
0.050
Why?
Disease Progression
2
2015
867
0.050
Why?
Health Status
1
2002
371
0.050
Why?
Alcohol Dehydrogenase
2
2010
40
0.050
Why?
Time Factors
1
2007
3352
0.050
Why?
Child, Preschool
1
2008
3972
0.050
Why?
Cohort Studies
2
2015
1444
0.050
Why?
Stereotaxic Techniques
2
2010
33
0.050
Why?
Arm
2
2009
50
0.050
Why?
Apoptosis
1
2005
1313
0.050
Why?
Anti-Bacterial Agents
1
2004
756
0.050
Why?
Polymerase Chain Reaction
1
2019
532
0.040
Why?
Oxidative Stress
3
2010
937
0.040
Why?
Injections, Intralesional
2
2008
40
0.040
Why?
Feces
1
2017
135
0.040
Why?
Adiponectin
1
2017
74
0.040
Why?
Risk Assessment
2
2017
1387
0.040
Why?
Phylogeny
1
2017
245
0.040
Why?
Reproducibility of Results
2
2015
1260
0.040
Why?
Child
1
2008
6482
0.040
Why?
Disease Models, Animal
2
2015
1638
0.040
Why?
Leptin
1
2017
156
0.040
Why?
Cost Savings
1
2015
73
0.040
Why?
Lipid Metabolism
1
2017
207
0.040
Why?
Protective Agents
1
2015
22
0.040
Why?
Taxoids
1
2015
46
0.040
Why?
MCF-7 Cells
1
2015
84
0.040
Why?
CpG Islands
1
2015
106
0.040
Why?
Mice, Inbred BALB C
2
2005
370
0.040
Why?
Infant, Newborn
1
2002
2657
0.030
Why?
Cyclophosphamide
1
2015
190
0.030
Why?
Touch
1
2013
25
0.030
Why?
Insulin
1
2017
513
0.030
Why?
Tumor Cells, Cultured
1
2015
508
0.030
Why?
Biopsy, Large-Core Needle
1
2013
30
0.030
Why?
Neoadjuvant Therapy
1
2015
114
0.030
Why?
Carcinoma
1
2015
152
0.030
Why?
Infant
1
2002
3499
0.030
Why?
Angiogenesis Inhibitors
1
2015
211
0.030
Why?
Radiotherapy, Adjuvant
1
2013
64
0.030
Why?
Hormones
1
2013
66
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2015
219
0.030
Why?
Chemotherapy, Adjuvant
1
2013
130
0.030
Why?
Injections, Intradermal
1
2011
15
0.030
Why?
X-Rays
1
2011
56
0.030
Why?
Cicatrix
1
2011
38
0.030
Why?
Intraoperative Period
1
2011
54
0.030
Why?
United States
1
2002
4825
0.030
Why?
Antineoplastic Agents
2
2013
1244
0.030
Why?
Allyl Compounds
1
2010
13
0.030
Why?
Sulfides
1
2010
31
0.030
Why?
Diagnosis, Differential
2
2004
1151
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2015
878
0.030
Why?
Chemokines
1
2010
95
0.030
Why?
Transforming Growth Factor beta1
1
2010
69
0.030
Why?
Predictive Value of Tests
2
2004
1044
0.030
Why?
Survival Rate
1
2012
995
0.020
Why?
African Americans
1
2015
701
0.020
Why?
Mammary Glands, Animal
1
2010
85
0.020
Why?
Double-Blind Method
1
2011
733
0.020
Why?
Pyrazoles
1
2010
118
0.020
Why?
Endoplasmic Reticulum
1
2010
119
0.020
Why?
Cell Division
1
2010
366
0.020
Why?
Tissue Extracts
1
2007
10
0.020
Why?
Pregnancy
1
2015
2422
0.020
Why?
Least-Squares Analysis
1
2007
52
0.020
Why?
Solubility
1
2007
71
0.020
Why?
Electrocoagulation
1
2007
12
0.020
Why?
Biotransformation
1
2007
122
0.020
Why?
Enteral Nutrition
1
2008
131
0.020
Why?
Observer Variation
1
2007
140
0.020
Why?
Enzyme Inhibitors
1
2010
439
0.020
Why?
Survival Analysis
1
2009
787
0.020
Why?
Staining and Labeling
1
2007
114
0.020
Why?
Positron-Emission Tomography
1
2008
311
0.020
Why?
E-Selectin
1
2005
20
0.020
Why?
Body Weights and Measures
1
2005
21
0.020
Why?
Wheat Germ Agglutinins
1
2005
4
0.020
Why?
Vaccines, Subunit
1
2005
21
0.020
Why?
Vaccines, DNA
1
2005
23
0.020
Why?
Cross Reactions
1
2005
55
0.020
Why?
Cytotoxicity, Immunologic
1
2005
62
0.020
Why?
Growth Inhibitors
1
2005
31
0.020
Why?
Gene Amplification
1
2005
57
0.020
Why?
Gadolinium
1
2005
59
0.020
Why?
Ligands
1
2005
248
0.020
Why?
Glucose Transporter Type 1
1
2004
17
0.020
Why?
Sampling Studies
1
2004
39
0.020
Why?
Free Radicals
1
2004
31
0.020
Why?
Enzyme Induction
1
2004
82
0.020
Why?
Corn Oil
1
2004
12
0.020
Why?
In Situ Hybridization, Fluorescence
1
2005
273
0.020
Why?
Imaging, Three-Dimensional
1
2005
174
0.020
Why?
MART-1 Antigen
1
2004
11
0.020
Why?
Eye Neoplasms
1
2004
10
0.020
Why?
Mice
2
2005
6232
0.020
Why?
Hyperplasia
1
2004
119
0.020
Why?
Injections
1
2003
63
0.020
Why?
Species Specificity
1
2004
216
0.020
Why?
Necrosis
1
2004
196
0.020
Why?
Dietary Carbohydrates
1
2004
89
0.020
Why?
Contrast Media
1
2005
233
0.020
Why?
Rats, Wistar
1
2004
251
0.020
Why?
Cytoplasm
1
2004
110
0.020
Why?
Amino Acid Sequence
1
2005
759
0.020
Why?
Cytochrome P-450 Enzyme System
1
2004
166
0.020
Why?
Regression Analysis
1
2004
468
0.020
Why?
Molecular Sequence Data
1
2005
970
0.020
Why?
Energy Intake
1
2004
184
0.020
Why?
Cell Nucleus
1
2004
208
0.020
Why?
Cell Proliferation
1
2008
1117
0.020
Why?
Antigens, Neoplasm
1
2004
167
0.020
Why?
Sex Characteristics
1
2004
193
0.020
Why?
Glutathione
1
2004
311
0.020
Why?
Multivariate Analysis
1
2004
678
0.020
Why?
Confidence Intervals
1
2002
178
0.010
Why?
Antioxidants
1
2004
294
0.010
Why?
Models, Theoretical
1
2002
197
0.010
Why?
Neoplasm Proteins
1
2004
379
0.010
Why?
Reoperation
1
2002
443
0.010
Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description